Medical Writing Trends in medical writing Trends in regulatory writing: A brief overview for aspiring medical writers
front-coverpng

Volume 28, Issue 3 - Trends in medical writing

Trends in regulatory writing: A brief overview for aspiring medical writers

Abstract

The EU regulatory system is undergoing a major overhaul. Several new pieces of legislation are now in place to enforce harmonisation and transparency in clinical trials while ensuring data security and individual privacy. New and aspiring medical writers need to be aware of trends in the regulatory landscape to adapt to new requirements in technical documentation. This article is an overview of the evolving trends in EU regulations for medical devices (Medical Device Regulation and In-Vitro Device Regulation) and data compliance (General Data Protection Regulation and EMA Policy 0070), and the impact of artificial intelligence (AI) on the global medical writing market.

Download the full article

References

  1. European Commission. The ‘Blue Guide’ on the implementation of EU products rules. 2016 [cited 2019 Aug 05]. Available from: https://eur-lex.europa.eu/legalcontent/ EN/TXT/PDF/?uri=CELEX:52 016XC0726(02)&from=BG.
  2. MedTech Europe. The European Medical Technology Industry 2019. [cited 2019 August 05. Available from: https://www.medtecheurope.org/wpcontent/ uploads/2019/04/The-European- Medical-Technology-Industry-in-figures- 2019-1.pdf.
  3. EUR-Lex. Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices. 1990 [cited2019 August 05]. Available from: https://eur-lex.europa.eu/legalcontent/ EN/TXT/?uri=CELEX%3 A31990L0385.
  4. EUR-Lex. Council Directive 93/42/EEC of 14 June 1993 concerning medical devices. 1993 [cited 2019 August 05]. Available from: https://eurlex. europa.eu/LexUriServ/LexUriServ.do? uri=CONSLEG:1993L0042:20071011: EN:PDF.
  5. EUR-Lex. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. 1998 [cited 2019 August 05]. Available from: https://eur-lex. europa.eu/eli/dir/1998/79/2012-01-11.
  6. Frumento C. French breast implants, the Medical Device Regulation, and a theoretical case study. Med Writ. 2017;26(2):39–40.
  7. US Food and Drug Administration. Unsafe and ineffective devices approved in the EU that were not approved in the US. Silver Spring, MD: US Food and Drug Administration; 2012 [cited 2019 August 05]. Available from: http://www.elsevierbi.com/~/media/ Supporting%20Documents/The%20Gray %20Sheet/38/20/FDA_ EU_ Devices_ Report.pdf.
  8. European Commission. Press release – New EU rules to ensure safety of medical devices. 2017 [cited 2019 August 05]. Available from: http://europa.eu/rapid/press-release_ MEMO-17- 848_en.htm.
  9. European Commission. Regulatory framework. [cited 2019 August 05]. Available from: https://ec.europa.eu/ growth/sectors/medical-devices/
  10. Eur-Lex. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices. 2017 [cited 2019 August 05]. Available from: https://eur-lex.europa.eu/eli/ reg/2017/745/oj.
  11. Eur-Lex. Regulation (EU) 2017/746 of the European Parliament and the Council of 5 April 2017 on in vitro diagnostic medical devices. 2017 [2019 August 05]. Available from: https://eur-lex.europa.eu/legalcontent/ EN/TXT/PDF/?uri=CELEX:32 017R0746&from=EN.
  12. Emergo. State of flux: European Notified Body numbers decrease further ahead of MDR, IVDR. 2019 [cited 2019 August 05]. Available from: https://www.emergobyul.com/blog/2019 /07/state-flux-european-notified-bodynumbers- decrease-further-ahead-mdr-ivdr.
  13. Mondaq.com. European Union: Update On The Implementation Of The European Medical Devices Regulation And In Vitro Diagnostics Regulation. 2019 [cited 2019 August 05]. Available from: http://www.mondaq.com/unitedstates/x/ 832142/Healthcare/Update+On+The+Im plementation+Of+The+European+Medica l+Devices+Regulation+And+In+Vitro+Di agnostics+Regulation.
  14. RAPS. EU MDR/IVDR: US Raises ‘Serious Concerns,’ Urges 3-Year Implementation Delay. 2019 [cited 2019 August 05] Available from: https://www.raps.org/news-andarticles/ news-articles/2019/8/eumdrivdr- us-raises-serious-concerns-urges-3 ?utm_source=MagnetMail&utm_medium =Email%20&utm_campaign=RF%20Toda y%20%7C%202%20August%202019.
  15. Vascular News. Europe braces for harder times in medical device innovation while US FDA eases regulations. 2018 [cited 2019 August 05]. Available from: https://vascularnews.com/europe-bracesfor- harder-times-in-medical-deviceinnovation-deviceinnovation- while-us-fda-easesregulations/.
  16. Parenteral Drug Association. European Implementation of Medical Device and IVD Regulations - Implications for Australia. 2019 [cited 2019 August 05]. Available from: https://pda.inloop.com/en/ article/123034?id=123034.
  17. Martinez-Clark JG. Latin America Offers Welcoming Entry Market Amid Tighter EU Regulations. 2019 [cited 2019 August 05]. Available from: https://www.meddeviceonline.com/doc/ latin-america-offers-welcoming-entrymarket- amid-tighter-eu-regulations-0001.
  18. GDPR.EU. Complete guide to GDPR compliance. [cited 2019 August 05]. Available from: https://gdpr.eu/.
  19. Thomas KB. Clinical trial disclosure and transparency: Regulation EU No. 536/2014, Public disclosure at the clinical trial level. Med Writ. 2018;27(2):7–17.
  20. European Medicines Agency. European Medicines Agency policy on publication of clinical data for medicinal products for human use (EMA Policy 0700). 2019 [cited 2019 August 05]. Available from: https://www.ema.europa.eu/en/document s/other/european-medicines-agencypolicy- publication-clinical-data-medicinalproducts- human-use_en.pdf.
  21. Billiones R. Anonymisation reports from 2016 to 2017: A preliminary analysis. Med Writ. 2018;27(2):22–6.
  22. Martinsson L. Preparing anonymisation reports in general and for an orphan drug in particular. Med Writ. 2018;27(2):27–30.
  23. CB Insights. The clinical trials industry needs a makeover. Here are the technologies looking to shake up the $65B market. 2019 [cited 2019 August 05] Available from: https://www.cbinsights.com/research/ clinical-trials-technologies/.
  24. CB Insights. The future of clinical trials: how ai & big tech could make drug development cheaper, faster, & more effective. 2018 [cited 2019 August 05]. Available from: https://www.cbinsights.com/research/ clinical-trials-ai-tech-disruption/
  25. Deloitte. Getting real with real-world evidence (RWE). 2018 [2019 August 05]. Available from: http://learn.deloitte.com/ rwe-survey-deloitte-insights.
  26. Cynober T. Artificial intelligence in oncology: Fantasy or reality? Labiotech.eu 2019 [cited 2019 August 05]. Available from: https://labiotech.eu/features/ artificial-intelligence-oncology/?utm_ source=twitter&utm_medium=social&ut m_campaign=meetedgar.
  27. World Health Organization. Looking at the pharmacovigilance: ensuring the safe use of medicines. [cited 2019 August 05]. Available from: http://apps.who.int/ medicinedocs/pdf/s6164e/s6164e.pdf.
  28. Clark R. 62% of Drug Safety Experts Say They’re Using AI to Improve Adverse Event Reporting. 2018 [cited 2019 August 05]. Available from: https://www.copyright. om/blog/drug-safety-using-ai-adverseevent- reporting/.
  29. Ventola CS. Big data and pharma - covigilance: Data mining for adverse drug events and interactions. 2018 [cited 2019 August 05]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969211/.
  30. Brennan Z. Synchrogenix acquires AI-assisted medical writing company ClinGenuity. Outsourcing-pharma 2015 [cited 2019 August 05]. Available from: https://www.outsourcingpharma. com/Article/2015/01/07/Synchr ogenix-acquires-AI-assisted-medicalwriting- company-ClinGenuity.
  31. Vincent J. The first AI-generated textbook shows what robot writers are actually good at. The Verge 2019 [cited2019 August 05]. Available from: https://www.theverge. com/2019/4/10/18304558/ai-writingacademic- research-book-springer-natureartificial- intelligence.
  32. Chandler DL. Can science writing be automated? MIT News 2019 [cited 2019 August 05]. Available from: http://news.mit.edu/2019/can-sciencewriting- be-automated-ai-0418.
  33. Extance A. How AI technology can tame the scientific literature. Nature 2018 [cited 05 August 2019]. Available from: https://www.nature.com/articles/d41586- 018-06617-5.
  34. GlobalNewswire. Medical writing market size worth around US$ 3.6 billion by 2026. Acumen Research and Consulting 2019 [cited 2019 August 05] Available from: https://www.globenewswire.com/newsrelease/ 2019/06/11/1867022/0/en/Medi cal-Writing-Market-Size-Worth-Around- US-3-6-bn-by-2026.html.
  35. Alechine E, Basu S, Chang C. Cheeky medical writers: Transitioning from academia to medical writing. Med. Writ. 2018; 28(1):20–3.

Search

Articles

Introduction
President's Message
EMWA News
Omics in silico and other trends in biomedical research: Impact on how and what we write
Catching the wave of lifestyle medicine
Artificial intelligence – will we be replaced by robots?
Now more than ever, scientists must speak up for science
When less is more: Medical writers as guardians of curated content
Predatory publishing – what medical communicators need to know
AMWA – EMWA – ISMPP Joint Position Statement on Predatory Publishing
How to combat medical misinformation with a sound content strategy
Subcontracting: Not for the faint of heart
Lay summaries and writing for patients: Where are we now and where are we going?
Clinical trial disclosure: Perspective from a medical writer for a contract research organisation
The 360° approach to authoring risk management plans
Trends in regulatory writing: A brief overview for aspiring medical writers
The medical writing landscape in China
News from the EMA
Regulatory Matters
Medical Communications and Writing for Patients
In the Bookstores
Getting Your Foot in the Door
Veterinary Medical Writing
Medical Devices
My First Medical Writing
Journal Watch
Good Writing Practice
Regulatory Public Disclosure
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: